Qlaris Bio, Inc., 2026-06-17
An SEC Form D private-offering notice from Dedham, MA, a $3,946,659 filer-stated offering target in Biotech. Filed 2026-06-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotechnology company developing first-in-class therapies for glaucoma and other ophthalmic conditions.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- VIRBELA INC., 2026-06-22, $800K, Dartmouth, MA
- Pierogi Therapeutics, Inc, 2026-06-17, $4M, Pittsburgh, PA
- Syndic8 DMS, LLC, 2026-06-18, $850K, Boston, MA
- PARLEY NEUROTECH INC, 2026-06-17, $300K, Denver, CO
- Scitara Corp, 2026-06-18, $5M, Marlborough, MA
- Reservoir Neuroscience, Inc., 2026-06-17, $8M, San Francisco, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.